The equity crowdfunding campaign for medical device company EzaLife concludes on April 6, 2026, on the platform StartEngine. The company developed the FDA-registered Button Huggie® device to address feeding tube securement, an issue affecting more than 1 million families each year. Founded by a pediatric surgeon who observed the shortcomings of existing methods, EzaLife's solution emphasizes simplicity, safety, and reliability.
Clinical data indicates the Button Huggie® achieves a 77% reduction in feeding tube dislodgement. The company has reported early commercial traction with $8,000 in pre-orders and $11,000 in sales within its first month. EzaLife has also secured backing from institutions including Children’s Hospital Colorado and CU Innovations. The device is protected by granted patents with global coverage, and the company has a pipeline for future product development.
With established momentum in both clinical and consumer markets, EzaLife is now prioritizing the scaling of its distribution network to increase access for patients and healthcare providers. Company leadership described this period as a pivotal moment for transitioning from foundation-building to a growth phase. The closing campaign provides a final window for investor participation in the company's efforts to expand the availability of its medical device.
